WASHINGTON, D.C. (April 20, 2005) -- The Biotechnology Industry Organization (BIO) has named Senator Michael Enzi (R, WY) as a “Legislator of the Year” for 2004-2005.
“As Chairman of the Committee on Health, Education, Labor and Pensions, Senator Enzi has been thoughtful and responsive to issues critical to the biotechnology community such as drug safety, importation, and access to affordable health care,” BIO President Jim Greenwood stated. “The Senator has also supported renewable biofuel energy, the elimination of trade barriers for agricultural biotech products, and the development of bioterror countermeasures in the BioShield Act. BIO thanks Senator Enzi for his leadership and for serving as our ally in the Senate.”
Senator Enzi received his award last night during a welcome reception for the more than 200 industry representatives from 33 states who gathered in DC for BIO’s Legislative Day. Today, they will participate in approximately 300 meetings with key members of the House and Senate to discuss the important issues facing the biotechnology industry, including drug safety, Medicare reimbursement, tax and capital formation, and reducing trade barriers for American farmers.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.